valproic acid has been researched along with Bladder Disorder, Neurogenic in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with trichostatin A at 50 ng/mL decreased the collagen level in cells from neurogenic bladders to almost normal levels (2." | 1.36 | The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study. ( Atala, A; Hodges, SJ; Mishra, N; Yoo, JJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hodges, SJ | 1 |
| Yoo, JJ | 1 |
| Mishra, N | 1 |
| Atala, A | 1 |
1 other study available for valproic acid and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study.
Topics: Azacitidine; Cells, Cultured; Collagen; Epigenesis, Genetic; Genetic Therapy; Histone Deacetylase In | 2010 |